ID: ALA5187979

Max Phase: Preclinical

Molecular Formula: C18H21FN4O2S

Molecular Weight: 376.46

Associated Items:

Representations

Canonical SMILES:  CC(=O)Nc1ncc(CN2CCCC(C(=O)Nc3ccc(F)cc3)C2)s1

Standard InChI:  InChI=1S/C18H21FN4O2S/c1-12(24)21-18-20-9-16(26-18)11-23-8-2-3-13(10-23)17(25)22-15-6-4-14(19)5-7-15/h4-7,9,13H,2-3,8,10-11H2,1H3,(H,22,25)(H,20,21,24)

Standard InChI Key:  XORLZQSCDLRCNG-UHFFFAOYSA-N

Associated Targets(Human)

Bifunctional protein NCOAT 460 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Hexosaminidase D 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

HT-22 3261 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 376.46Molecular Weight (Monoisotopic): 376.1369AlogP: 3.09#Rotatable Bonds: 5
Polar Surface Area: 74.33Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.09CX Basic pKa: 7.22CX LogP: 2.08CX LogD: 2.09
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.84Np Likeness Score: -2.50

References

1. Li X, Han J, Bujaranipalli S, He J, Kim EY, Kim H, Im JH, Cho WJ..  (2022)  Structure-based discovery and development of novel O-GlcNAcase inhibitors for the treatment of Alzheimer's disease.,  238  [PMID:35588599] [10.1016/j.ejmech.2022.114444]

Source